Maria Hristopoulos

1.9k total citations
15 papers, 687 citations indexed

About

Maria Hristopoulos is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Maria Hristopoulos has authored 15 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Oncology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Maria Hristopoulos's work include Monoclonal and Polyclonal Antibodies Research (9 papers), CAR-T cell therapy research (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). Maria Hristopoulos is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), CAR-T cell therapy research (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). Maria Hristopoulos collaborates with scholars based in United States, Switzerland and Canada. Maria Hristopoulos's co-authors include Ji Li, Klára Tótpál, Robyn Clark, Teemu T. Junttila, Dionysos Slaga, Jeffrey M. Dodd‐o, David B. Pearse, Kedan Lin, Brad Bolon and Avi Ashkenazi and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Maria Hristopoulos

13 papers receiving 655 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Hristopoulos United States 10 358 279 265 179 72 15 687
Alei Feng China 14 261 0.7× 168 0.6× 112 0.4× 252 1.4× 37 0.5× 27 686
Harukaze Yamamoto Japan 12 548 1.5× 127 0.5× 285 1.1× 133 0.7× 37 0.5× 25 794
Yu Oyama Japan 15 171 0.5× 106 0.4× 135 0.5× 120 0.7× 29 0.4× 41 753
Takanori Maruyama Japan 15 495 1.4× 120 0.4× 113 0.4× 474 2.6× 28 0.4× 24 856
Masahiro Ohara Japan 16 299 0.8× 193 0.7× 86 0.3× 119 0.7× 34 0.5× 44 654
Ted Shih United States 6 222 0.6× 201 0.7× 107 0.4× 47 0.3× 33 0.5× 9 524
Christina Williamson United States 13 189 0.5× 534 1.9× 102 0.4× 208 1.2× 30 0.4× 25 979
Brian S. Henick United States 14 511 1.4× 189 0.7× 87 0.3× 306 1.7× 38 0.5× 57 854

Countries citing papers authored by Maria Hristopoulos

Since Specialization
Citations

This map shows the geographic impact of Maria Hristopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Hristopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Hristopoulos more than expected).

Fields of papers citing papers by Maria Hristopoulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Hristopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Hristopoulos. The network helps show where Maria Hristopoulos may publish in the future.

Co-authorship network of co-authors of Maria Hristopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Hristopoulos. A scholar is included among the top collaborators of Maria Hristopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Hristopoulos. Maria Hristopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Diefenbach, Catherine, Elizabeth Budde, Julio C. Chávez, et al.. (2021). PROMISING CLINICAL DATA FROM DOSE ESCALATION IN A PHASE IB/II ONGOING STUDY OF MOSUNETUZUMAB WITH POLATUZUMAB VEDOTIN FOR RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN’S LYMPHOMA. Hematological Oncology. 39(S2). 4 indexed citations
3.
4.
Li, Ji, Ji Li, Robert Piskol, et al.. (2019). CD3 bispecific antibody–induced cytokine release is dispensable for cytotoxic T cell activity. Science Translational Medicine. 11(508). 128 indexed citations
5.
Slaga, Dionysos, Diego Ellerman, T. Noelle Lombana, et al.. (2018). Avidity-based binding to HER2 results in selective killing of HER2-overexpressing cells by anti-HER2/CD3. Science Translational Medicine. 10(463). 93 indexed citations
6.
Mandikian, Danielle, Ji Li, Jeffrey Eastham‐Anderson, et al.. (2018). Relative Target Affinities of T-Cell–Dependent Bispecific Antibodies Determine Biodistribution in a Solid Tumor Mouse Model. Molecular Cancer Therapeutics. 17(4). 776–785. 112 indexed citations
7.
Wang, Peiyin, Maria Hristopoulos, Robyn Clark, et al.. (2017). Abstract 3628: T cell-dependent bispecific antibody anti-CD79b/CD3 as a potential therapy for B-cell malignancies. Cancer Research. 77(13_Supplement). 3628–3628. 1 indexed citations
8.
9.
Lin, Kedan, Bonnee Rubinfeld, Crystal Zhang, et al.. (2015). Preclinical Development of an Anti-NaPi2b (SLC34A2) Antibody–Drug Conjugate as a Therapeutic for Non–Small Cell Lung and Ovarian Cancers. Clinical Cancer Research. 21(22). 5139–5150. 65 indexed citations
10.
Lin, Kedan, Crystal Zhang, Eric B. Harstad, et al.. (2013). Abstract 5619: Preclinical development of anti-SLC34A2 antibody drug conjugate as a therapeutic for non-small cell lung and ovarian cancers.. Cancer Research. 73(8_Supplement). 5619–5619.
11.
French, Dorothy, Benjamin C. Lin, Man Ping Wang, et al.. (2012). Targeting FGFR4 Inhibits Hepatocellular Carcinoma in Preclinical Mouse Models. PLoS ONE. 7(5). e36713–e36713. 167 indexed citations
12.
Dodd‐o, Jeffrey M., Maria Hristopoulos, Daniel O. Scharfstein, et al.. (2008). Interactive effects of mechanical ventilation and kidney health on lung function in an in vivo mouse model. American Journal of Physiology-Lung Cellular and Molecular Physiology. 296(1). L3–L11. 27 indexed citations
13.
Dodd‐o, Jeffrey M., Maria Hristopoulos, Kathleen K. Kibler, et al.. (2008). The role of natriuretic peptide receptor-A signaling in unilateral lung ischemia-reperfusion injury in the intact mouse. American Journal of Physiology-Lung Cellular and Molecular Physiology. 294(4). L714–L723. 21 indexed citations
14.
Dodd‐o, Jeffrey M., et al.. (2006). Strain-specific differences in sensitivity to ischemia-reperfusion lung injury in mice. Journal of Applied Physiology. 100(5). 1590–1595. 35 indexed citations
15.
Dodd‐o, Jeffrey M., Maria Hristopoulos, Nauder Faraday, & David B. Pearse. (2003). Effect of ischemia and reperfusion without airway occlusion on vascular barrier function in the in vivo mouse lung. Journal of Applied Physiology. 95(5). 1971–1978. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alei Feng Breakdown of academic impact, for papers by Harukaze Yamamoto Breakdown of academic impact, for papers by Yu Oyama Breakdown of academic impact, for papers by Takanori Maruyama Breakdown of academic impact, for papers by Masahiro Ohara Breakdown of academic impact, for papers by Ted Shih Breakdown of academic impact, for papers by Christina Williamson Breakdown of academic impact, for papers by Brian S. Henick
Rankless by CCL
2026